Yadira Torres MAS/LinkedIn
Sep 15, 2026, 11:55
Yadira Torres MAS: Predicting Chronic Immune Thrombocytopenia in Children
Yadira Torres MAS, Executive Director at Children’s Hospital Los Angeles, shared CHLA’s post on LinkedIn:
“A new study led by CHLA may help answer a key question for physicians treating children with immune thrombocytopenia (ITP):
Which patients will recover on their own, and which will develop chronic disease?”
Children’s Hospital Los Angeles (CHLA) shared a post on LinkedIn:
“Which children with immune thrombocytopenia (ITP) will recover on their own and which will develop chronic disease?
A multicenter study led by CHLA’s Dr. Taylor Kim validated a prediction model that could help physicians answer that question when a child is first diagnosed.”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 13:50Richard Godin: Challenges in Diagnosing Homozygous Familial Hypercholesterolemia
-
Sep 15, 2026, 13:42Sujan Sivasubramaniyam: Three Decades of Progress for Children with Haemophilia in Morocco
-
Sep 15, 2026, 13:31Mohammed Alkhani: Challenging the Conventional Approach to Paget-Schroetter Syndrome
-
Sep 15, 2026, 13:29Shadi Tabibian: Three Years of Progress Toward Life Beyond Hemophilia
-
Sep 15, 2026, 13:24Randall Curtis: Very Rewarding Week as a Co-Author, With a New Article in Production
-
Sep 15, 2026, 12:55Christopher Cannon: Calcium Scoring for Better Cardiovascular Risk Assessment
-
Sep 15, 2026, 12:55Lisa Krishtul: A Little Time Can Save a Life
-
Sep 15, 2026, 12:46Wolfgang Miesbach: Blood Centres as Health Weather Stations
-
Sep 15, 2026, 12:40Ronald F. Feinberg: Insulin Resistance May Be an Overlooked Cardiovascular Risk Factor